Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial
Italian Association for Cancer Research; Italian Ministry of Health; Horizon2020; National Cancer Institute (NCI); Gensignia LifeScience.
Authors
- Paola Suatoni (ORCID: https://orcid.org/0000-0001-5513-5381)
- Miriam Segale (ORCID: https://orcid.org/0000-0001-9845-1616)
- Roberta Eufrasia Ledda (ORCID: https://orcid.org/0000-0003-3184-2676)
- Luigi Rolli (ORCID: https://orcid.org/0000-0002-6673-5785)
- Mattia Boeri (ORCID: https://orcid.org/0000-0001-7106-3138)
- Gabriella Sozzi (ORCID: https://orcid.org/0000-0001-9360-6914)
- Ugo Pastorino (ORCID: https://orcid.org/0000-0001-9974-7902)
- Federica Sabia (ORCID: https://orcid.org/0000-0001-7334-8962)
- Anna Cantarutti (ORCID: https://orcid.org/0000-0002-3700-780X)
- Giovanni Corrao (ORCID: https://orcid.org/0000-0002-1034-8444)
- Camilla Valsecchi
- Alfonso Marchianò (ORCID: https://orcid.org/0000-0003-1379-878X)
- Maurizio Balbi (ORCID: https://orcid.org/0000-0002-8436-3655)
- Anna Zanghì (ORCID: https://orcid.org/0009-0000-7147-8480)
Institutions
- University of Parma (IT)
- Ospedale San Luigi Gonzaga (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1016/j.lanepe.2024.101070
- Citations
- 11
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.61
Funders
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
- National Cancer Institute